1. Human growth hormone was prepared from acetone-dried residues after extraction of gonadotrophins from pituitary glands. 2. Crude growth hormone was purified by gel filtration on Sephadex, resulting in a product that is soluble in water or 0.5% sodium chloride. It is painless on injection and shows a twofold increase in biological potency. Aggregation of growth hormone on Sephadex columns can be avoided by the addition of urea (6M) and EDTA (1mM) to the buffer. 3. Growth hormone appeared as a single component from Sephadex and ion-exchange columns and sedimented as a single boundary in the ultracentrifuge. In the circular disk electrophoresis, however, the growth hormone showed one faster and two slower-moving anionic components. 4. These components were isolated by preparative electrophoresis on polyacrylamide columns. The purified growth hormone and its three components sedimented as single boundaries with coefficients 2-62, 2-66, 2-66 and 2-83s respectively. 5. Amino acid analyses of the purified growth hormone and its components were closely related. End-group analysis of purified growth hormone and its components showed only phenylalanine at both N-and C-terminals. 6 . The purified growth hormone and its components were essentially free of other pituitary hormones, but contained significant prolactin activity. The biochemical similarities among the electrophoretic components of human growth hormone and the presence of the same three components in the growth hormone prepared from a single human pituitary gland suggest polymorphism of a biologically active protein molecule.
Preparations of human growth hormone have shown three or four components in agar-gel (Laron & Assa, 1962a) , starch-gel (Ferguson & Wallace, 1961; Barrett, Friesen & Astwood, 1962) , polyacrylamide-gel (Reisfeld, Lewis, Brink & Steelman, 1962;  Reisfeld, Hallows, Williams, Brink & Steelman, 1963) and starch-grain (W. M. Hunter, personal communication) electrophoreses. Reports intheliteraturehavealsoindicatedbiological (Laron, Assa & Menache, 1963) , immunological (Laron & Assa, 1962b) Raben (1959) .
A single human pituitary gland was also extracted for growth hormone by the method of Raben (1959) . The growth hormone obtained was filtered through Sephadex G-200 and the growth-hormone fraction was analysed by polyacrylamide-gel electrophoresis.
Exclusion chromatography on cross-linked dextran (Sephadex). Sephadex  Uppsala, Sweden) were allowed to swell overnight in 0.9% NaCl, washed three times with water and equilibrated with 0-05m-borate-0-05M-KCI buffer, pH8-6, by repeated washings. Eluates from the column were either scanned through a Uvicord instrument (LKB Instrument Co., Stockholm, Sweden) or examined in a spectrophotometer (Beckman Instruments, Fullerton, Calif., U.S.A.) for E278.
Crude growth hormone (200mg.) was suspended in 711 4-S5ml. of water, solubilized by the addition of 6-8 drops of 01N-NaOH and applied to a column (2-5 cm. x 36 cm.) of Sephadex G-200 equilibrated with 0 05M-borate-0-05M-KCI buffer, pH 8.6. The column was eluted at a flow rate of 12ml./hr. Three fractions (I, II and III) were obtained ( Fig. la) and assayed for growth-hormone activity. Fraction II, containing the growth hormone, was recovered by dialysis for 24hr. against water followed by freezedrying.
Fraction II from Sephadex G-200 filtration in batches of 100mg. was chromatographed on columns (2.5cm. x44cm.) of Sephadex G-100 in 0-05m-borate-0-05M-KCl buffer, pH8-6. Fractions IIA, IIB and IIC (Fig. lb) were obtained and assayed for growth-hormone activity. The growth-hormone activity was recovered in fraction IIB.
Fraction IIB (30mg.) was refiltered through Sephadex G-100 in 0 05M-borate-0 05m-KCl buffer, pH8-6, without (Fig. Ic) andwith (Fig. ld) urea (6M) and EDTA (1 mM).
A 30mg. portion of fraction IIB was chromatographed on a column (2 cm. x 34cm.) of Sephadex G-50 in 0-05M-borate-0 05M-KCl buffer, pH8-6, prepared both without (Fig. le) and with ( Fig. If) urea (6M) and EDTA (1mM). Growth-hormone fractions appeared unretarded from Sephadex G-50 columns.
Ion-exchange chromatography. Fraction IIB (30mg.) was studied further by ion-exchange chromatography on DEAE-cellulose with a discontinuous pH gradient between 0-05M-sodium phosphate buffer, pH7-7, and 0-05M-sodium acetate-acetic acid buffer, pH3-5, in a Varigrad (Buehler Instrument Co., Fort Tube no. Fig. 1 . Gel filtration of: (a) human growth hormone on a column (2-5 cm. x 36 cm.) of Sephadex G-200 in 0-05M-borate-0-05M-KCl buffer, pH8-6 (growth-hormone activity was associated with fraction II); (b) fraction II on a column (2-5cm.x44cm.) of Sephadex G-100 in 0-05M-borate-0-05M-KCl buffer, pH8-6; (c) fraction IIB on a column (2-5cm. x 44cm.) of Sephadex G-100 in 0-05m-borate-0-05M-KCl buffer, pH8-6; (d) fraction IIB on a column (2-5 cm. x 44cm.) of Sephadex G-100 in 0 05M-borate-0-05M-KCl buffer, pH8-6, containing urea (6M) and EDTA (1mM); (e) fraction IIB on a column (2 cm. x 34cm.) of Sephadex G-50 in 0-05M-borate-0 05M-KCl buffer, pH8.6; (f) fraction IIB on a column (2cm. x 34cm.) of Sephadex G-50 in 0 05m-borate-0-05M-KCl buffer, pH8-6, containing urea (6M) and EDTA (1mM). Sephadex G-200, G-100 and G-50 columns were eluted at the rate of 12ml./hr. hormone fraction IIB (30mg.) was chromatographed on columns of DEAE-Sephadex as described by Free & Sonenberg (1965) for bovine growth hormone and on Amberlite IRC-50 resin according to the procedures of Papkoff & Li (1958) and Li & Papkoff (1956) for bovine and human growth hormones respectively. The growth hormone was eluted from these columns in single fractions.
Ultracentrifugal analy8i8. Since growth-hormone fraction IIB appeared from Sephadex and ion-exchange columns as a single fraction, a 1% (w/v) solution of fraction IIB in 0 02M-phosphate buffer, pH7-0, was examined in a Beckman Spinco model E ultracentrifuge. Sedimentation coefficients were calculated from the results obtained at five different concentrations of growth hormone and extrapolated to zero concentration. Temperature was maintained at 20+0.020 with the RTIC (rotor temperature indicator control).
The sedimentation coefficients of the three electrophoretic components IIB1, IIB2 and IIB3 obtained from the polyacrylamide-gel column (see below) were also determined in the same way.
Di8k electrophoresi8 in polyacrylamide gel. Growthhormone fractions IIB from Sephadex G-100, DEAEcellulose, DEAE-Sephadex and Amberlite IRC-50 columns were subjected to analytical disk electrophoresis (Ornstein & Davis, 1961) in polyacrylamide gel (Canalco, Bethesda, Md., U.S.A.) in 0.05 M-tris-glycine buffer, pH8.6, with a current of 5mA for 30min. at 125v/tube (7 cm. x 0.5 cm.). The gels were stained with Amido Black 10B and excess of stain was removed by electrophoresis in 15% (v/v) acetic acid. Fraction IIB from the Sephadex G-100 and ionexchange columns showed one faster and two slower-moving anionic components (1, 2 and 3 in Fig. 2a ). These components were isolated by preparative polyacrylamide column electrophoresis and re-examined by analytical disk electrophoresis (Figs. 2b, 2c and 2d).
Preparative polyacrylamide-gel electrophore8i8. The three electrophoretic components of human growth-hormone IIB lIB, fraction IIB were separated on a preparative polyacrylamide-gel column (catalogue no. 3-1700; Buchler Instruments Inc.) with the tris-urea discontinuous buffer system of Jovin, Chrambach & Naughton (1964 activity by the tibia test (Greenspan, Li, Simpson & Evans, 1949) RESULTS AND DISCUSSION There is increasing interest in the recovery of all hormones during extraction of human pituitaries. In the present study, gonadotrophins were extracted before growth hormone. The growthhormone yields of 3 56g. and 3-84g./1bOg. of acetone-dried powder for two separate batches (Table 1) were not significantly different from the yields of 3-1-4-6g. reported by Raben (1959) . The yield of the crude gonadotrophin fraction was 3-3-5g./lOOg. of acetone-dried powder and contained 243 + 53-1% of the standard NIH-FSH-S2 activity as determined by the augmentation assay of Steelman & Pohley (1953) .
The results from 13 Sephadex G-200 columns indicated that inactive fraction I and growthhormone fraction II (Fig. la) contained 22 and 78% respectively of the material recovered from the column (Table 1) . Fraction III did not show any yield as protein and was biologically inactive. This distribution of protein in fractions I and II was constant for loads of crude growth hormone ranging from 60 to 200mg. applied to Sephadex G-200 columns. When fraction II was chromatographed on Sephadex G-100 columns (Fig. lb) the average of seven experiments showed that 60% of the material appeared in fraction IIB, containing Vol. 100 GROWTH-HORMONE COMPONENTS OF HUMAN PITUITARY the growth hormone, and that 40% of the material was in the unretarded inactive fraction IIA.
When fraction IIB from the Sephadex G-100 column was rechromatographed on a Sephadex G-100 column (Fig. lc) 20% of the material again appeared unretarded. However, when 30mg. of fraction IIB was equilibrated with 0 05M-borate-0.05M-potassium chloride buffer, pH8-6, containing urea (6m) and EDTA (1mM) by overnight dialysis and chromatographed on a column (2cm. x 40cm.) of Sephadex G-100 (Fig. ld) the growthhormone protein appeared as a single retarded fraction with no indication of unretarded material. From the Sephadex G-50 column (Fig. le) fraction IIB appeared unretarded with a slight fastermoving shoulder, indicating the formation of highmolecular-weight material. The effect of 6M-urea in preventing the formation of high-molecularweight material was confirmed by the appearance of a single symmetrical retarded component when 30mg. of fraction IIB from the Sephadex G-100 column was rechromatographed on a column (2 cm. x 40 cm.) of Sephadex G-50 (Fig. lf) in 0 05M-borate-0 05M-potassium chloride buffer, pH 8-6, containing urea (6M) and EDTA (lmm). These results suggest aggregation of fraction II into a high-molecular-weight material during dialysis, freeze-drying and refractionation through Sephadex G-100, and further suggest that this aggregation of growth hormone can be prevented by the addition of urea (6M) and EDTA (1mM) to the 0 05M-borate-0 05M-potassium chloride buffer, pH8.6. W. M. Hunter (personal communication) has also obtained evidence for the transformation of fraction II-like material into high-molecularweight fraction I by reheating to 700 the acetic acid-acetone extract of whole acetone-dried pituitaries.
Sedimentation of fraction IIB as a single boundary in the analytical centrifuge with a coefficient of 2'62s indicated that filtration through Sephadex columns has been successful in selecting protein of similar molecular weight. The S20,W, value 2'62s is in good agreement with the coefficient 2*5s for human growth hormone described by Squire & Pederson (1961) .
Fraction IIB and growth-hormone fractions from Sephadex, DEAE-cellulose, DEAE-Sephadex and Amberlite IRC ion-exchange columns showed three anionic components, IIB1, IIB2 and IIB3 (Fig. 2a) , in polyacrylamide-gel disk electrophoresis. When the components from the preparative polyacrylamide-gel columns were re-examined in analytical gels, component IIB1 appeared as a Table 2 . Amino acid composition of human growth hormone Experimental details are given in the text. The results are expressed as residues/mol. of mol.wt. 27100 (Wilhelmi, 1959) .
Amino acid composition (residues/mol.) (Fig. 2b) ; components IIB2 and IIB3 showed, however, one major and a light diffuse band (Figs. 2c and 2d) . Fractions IIB and IIB1, IIB2 and IIB3 sedimented as single boundaries in the analytical ultracentrifuge with sedimentation coefficients 2*62, 2.66, 2-66 and 2-83s respectively. This observation implies that fractions IIB1, IIB2 and IIB3 may exist as separable entities in precursor fraction IIB. The disk-electrophoretic pattem of human growth hormone prepared from a single pituitary and filtered through Sephadex G-200 also showed three anionic components similar to those of the growth hormone prepared from a large batch of glands. One may conclude from this that each pituitary contains these three peptides with growth-hormone activity. The possibility remains that chemical procedures may cause the appearance of three subfractions of a single protein molecule.
The amino acid compositions of fractions IIB1, IIB2 and IIB3 were compared with that of fraction IIB and with the published data of Wilhelmi (1959) and Dixon & Li (1962) on growth-hormone preparations ( Table 2 ). The total amide nitrogen residues in components IIB1, IIB2 and IIB3 were 38, 44 and 46 respectively. The amide nitrogen residues imply six and eight more carboxyl groups in IIB1 than in IIB2 and IIB3 respectively, and two more carboxyl groups in IIB2 than in IIB3. These differences may be related to the electrophoretic mobilities of the components in the polyacrylamide gel. Since the amino acid analyses of fractions IIB, IIB1, IIB2 and IIB3 are not widely divergent, the differences in total nitrogen residues might be due to loss of one or more side-chain amide groups. The similarity of the amino acid compositions of fraction IIB to those of the growth-hormone preparations of Wilhelmi (1959) and Dixon & Li (1962) is noted. W. M. Hunter (personal communication) and Meisinger, Cirillo, Davis & Reisfeld (1964) have also shown the similarity in the amino acid compositions of the growth hormone and electrophoretic components obtained by starch-grain and polyacrylamide-gel electrophoresis.
Preliminary end-group analyses of fractions IIB, IIB1, IIB2 and IIB3 indicated the presence of phenylalanine at both the N-and C-terminals. During C-terminal analysis phenylalanine appeared as the main product of carboxypeptidase digestion.
Biological activity in rat8. Bioassay revealed 0*78 unit of growth hormone/mg. in crude growth hormone, 1*5 units/mg. in fraction II and 0-87 unit/ mg. in fraction IIB. These results indicate that the filtration of crude growth hormone on Sephadex G-200 resulted in the elimination of 22% of biologically inactive high-molecular-weight material with approximately twofold increase in biological activity (Table 1) . Reisfeld et al. (1963) and W. M.
Hunter (personal communication) have also claimed a twofold increase in the specific activity of the growth hormone by purification on Sephadex G-200 columns. Sephadex G-100 filtration apparently resulted in decreased activity that may be Standard (NIH-GH-B7) 100,g. show any follicle-stimulating-hormone activity in the Steelman & Pohley (1953) assay. Also, 9 and 45,ug. of fraction IIB failed to deplete ovarian ascorbic acid (Parlow, 1961) , indicating the absence of luteinizing hormone at these dose levels. Biological activity in man. In a 42-day complete balance study in a 17-year-old white male with idiopathic hypopituitarism crude growth hormone and fractions I, II and IIA and IIB were compared.
Fraction II was more active than crude human growth hormone in increasingplasma free fatty acids and urinary calcium and in decreasing urinary nitrogen, phosphorus, sodium and potassium. Fraction IIA was inactive and permitted urinary values to return towards control levels. Fraction IIB was slightly more active than fraction II in increasing urinary calcium and decreasing urinary nitrogen. Thus, in spite of the recognized tendency for the metabolic responses to human growth hormone to decrease with time, it was apparent that fraction IIB was slightly more active than fraction II, which in turn was much more active than crude human growth hormone. Fractions IA and IIA were virtually inactive.
Crude human growth hormone and fractions I and II were studied in a 15-year-old boy with idiopathic hypopituitarism. Fraction II was more active than crude growth hormone in decreasing urinary nitrogen, phosphorus, potassium and hydroxyproline. Fraction I was virtually inactive.
Fractions I and II were compared in a 48-year-old obese normal woman. Fraction II was more active than fraction I in decreasing urinary nitrogen, phosphorus and potassium and in increasing urinary calcium. Fraction I was virtually without effect.
Solubility of purified fraction8. Growth hormone prepared by Raben's (1959) procedure is usually solubilized by the addition of 01 N-hydrochloric acid, which makes the preparation painful on injection. Filtration of crude growth hormone through Sephadex G-200 results in a product that is freely soluble in water or 0.5% sodium chloride and that is painless on injection.
